HYPERPHAGIA
Clinical trials for HYPERPHAGIA explained in plain language.
Never miss a new study
Get alerted when new HYPERPHAGIA trials appear
Sign up with your email to follow new studies for HYPERPHAGIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug targets uncontrollable hunger in rare genetic disorder
Disease control OngoingThis study is testing whether a daily injection called setmelanotide can help people with Prader-Willi Syndrome manage their weight and reduce extreme hunger behaviors. About 20 participants aged 6-65 will receive the medication for up to one year while researchers monitor safety…
Matched conditions: HYPERPHAGIA
Phase: PHASE2 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug trial aims to tame uncontrollable hunger in rare genetic disorder
Disease control TerminatedThis study is testing whether ARD-101 can safely help control the extreme, life-threatening hunger experienced by people with Prader-Willi syndrome over a full year. It follows 90 patients who previously participated in a related 12-week trial, asking them to take the medication …
Matched conditions: HYPERPHAGIA
Phase: PHASE3 • Sponsor: Aardvark Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New drug trial aims to tame uncontrollable hunger in rare genetic disorder
Symptom relief TerminatedThis study is testing whether an investigational drug called ARD-101 can reduce the extreme, life-threatening hunger (hyperphagia) experienced by people with Prader-Willi syndrome. About 90 participants, aged 7 and older, will take either ARD-101 or a placebo pill daily for 12 we…
Matched conditions: HYPERPHAGIA
Phase: PHASE3 • Sponsor: Aardvark Therapeutics, Inc. • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC
-
Scientists hunt for genetic clues behind severe childhood obesity
Knowledge-focused OngoingThis study aims to understand the genetic causes of severe childhood obesity and related conditions like Bardet-Biedl Syndrome. Researchers will analyze genetic information from 1,000 children and adults in Germany who developed severe obesity early in life. The goal is to identi…
Matched conditions: HYPERPHAGIA
Sponsor: Rolfs Consulting und Verwaltungs-GmbH (RCV) • Aim: Knowledge-focused
Last updated Mar 03, 2026 14:05 UTC